Nizatidine
| Use attributes for filter ! | |
| Molar mass | 331. 46 g/mol |
|---|---|
| CAS ID | 76963-41-2 |
| Protein binding | 35% |
| Formula | C12H21N5O2S2 |
| Trade name | Axid, Tazac |
| Elimination half-life | 1–2 hours |
| Music groups | Famotidine |
| Ranitidine | |
| Cimetidine | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2922124 |
About Nizatidine
Nizatidine is a histamine H₂ receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. It was patented in 1980 and approved for medical use in 1988. It was developed by Eli Lilly. Brand names include Tazac and Axid.